Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
-
Market Cap
1.96M
Enterprise Value
-1.60M
Income
-11.06M
Sales
0.36M
Book/sh
2.38
Cash/sh
2.60
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
14
IPO
Jun 28, 1999
P/E
-
Forward P/E
-
PEG
-
P/S
5.44
P/B
0.60
P/C
0.55
P/FCF
-
EV/EBITDA
-
EV/Sales
-4.44
Quick Ratio
2.35
Current Ratio
2.35
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-22.40
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
24.33% 43.92%
Sales past 3/5Y
44.27% 36.11%
EPS Y/Y TTM
25.62%
Sales Y/Y TTM
-8.47%
EPS Q/Q
80.98%
Sales Q/Q
-7.32%
Insider Own
6.22%
Insider Trans
0.00%
Inst Own
10.43%
Inst Trans
9.08%
ROA
-147.75%
ROE
-241.14%
ROIC
-365.43%
Gross Margin
33.24%
Oper. Margin
-3975.00%
Profit Margin
-3089.55%
SMA20
-5.71%
SMA50
-28.01%
SMA200
-72.29%
Trades
Shs Outstand
1.38M
Shs Float
1.30M
52W High
28.99 -95.10%
52W Low
1.28 10.94%
Volatility
8.16% 9.44%
ATR (14)
0.16
RSI (14)
35.67
Beta
0.83
Rel Volume
0.00
Avg Volume
29.25K
Volume
0
Perf Week
-11.25%
Perf Month
-7.79%
Perf Quarter
-66.67%
Perf Half Y
-61.95%
Perf YTD
-93.96%
Perf Year
-94.66%
Perf 3Y
-96.06%
Perf 5Y
-98.90%
Perf 10Y
-100.00%
Prev Close
1.42
Price
1.42
Change %
0.00%
Consensus
Strong Buy
Avg. Price Target
$20.00
Implied Upside
+1,308.5%
Analysts1incl. previous ratings
Rating Distribution0 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 06, 2026Downgrade
MMaxim Group
Buy → Hold
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Interim CEO & DirectorMr. Mika Grasso
CFO & TreasurerMs. Anna Skowron
Head of Global Commercial OperationsMs. Crystal Romano